Vithal M Kulkarni Selected Research

1- biphenyl- 4- yl- 2- (4- nitrophenoxy)ethanone

1/2011	Effect of a novel biphenyl compound, VMNS2e on ob/ob mice.
12/2010	Novel biphenyl compound, VMNS2e, ameliorates streptozotocin-induced diabetic nephropathy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vithal M Kulkarni Research Topics

Disease

3	Inflammation (Inflammations) 05/2023 - 01/2006
3	Neoplasms (Cancer) 01/2022 - 12/2006
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2020
2	Rheumatoid Arthritis 11/2011 - 08/2010
2	Body Weight (Weight, Body) 01/2011 - 12/2010
1	HIV Infections (HIV Infection) 05/2023
1	Alzheimer Disease (Alzheimer's Disease) 04/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Asthma (Bronchial Asthma) 11/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2011
1	Insulin Resistance 01/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2010
1	Osteoarthritis 08/2010
1	Pain (Aches) 08/2010
1	Obesity 06/2007
1	Type 2 Diabetes Mellitus (MODY) 06/2007
1	Edema (Dropsy) 01/2006
1	Granuloma 01/2006
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2004
1	Infections 04/2002
1	Mycoses (Diseases, Fungus) 04/2002

Drug/Important Bio-Agent (IBA)

3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022 - 12/2020
2	LipidsIBA 04/2021 - 01/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 12/2020
2	EnzymesIBA 11/2011 - 04/2002
2	Blood Glucose (Blood Sugar)IBA 01/2011 - 12/2010
2	1- biphenyl- 4- yl- 2- (4- nitrophenoxy)ethanoneIBA 01/2011 - 12/2010
2	diphenyl (biphenyl)IBA 12/2010 - 01/2006
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 12/2010 - 06/2007
1	Antineoplastic Agents (Antineoplastics)IBA 05/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 04/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2021
1	Rosiglitazone (Avandia)FDA Link 04/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2021
1	Amyloid beta-PeptidesIBA 04/2021
1	Pioglitazone (Actos)FDA Link 04/2021
1	raf KinasesIBA 01/2021
1	piperineIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Proto-Oncogene Proteins A-rafIBA 01/2021
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	oxidized low density lipoproteinIBA 01/2011
1	CholesterolIBA 01/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2011
1	Insulin (Novolin)FDA Link 01/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2011
1	FructosamineIBA 01/2011
1	Streptozocin (Streptozotocin)FDA Link 12/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2010
1	Insulin ReceptorIBA 06/2007
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2006
1	CarrageenanIBA 01/2006
1	Analgesics (Analgesic Drugs)IBA 01/2006
1	Celecoxib (Celebrex)FDA Link 01/2006
1	Aspartic Acid ProteasesIBA 04/2002
1	Virulence Factors (Pathogenicity Factors)IBA 04/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2004
1	Glycemic Control 01/2011